Skip to content

SRTA SRTA Clinical — Revenue

Other segment segments

Logistics
$47.6M

Similar metrics at other companies

Maximus logo
MMSClinical Services — Revenue
$530.81M+5.3%
Simulations Plus logo
SLPClinical Operations — Revenue
$415K-53.6%
Fortrea Holdings Inc. logo
FTREClinical Services Segment — Revenue
$636.5M-2.3%
The Oncology Institute, Inc. logo
TOIClinical trials & other — Total operating revenue
$813K-60.2%
Evolent Health, Inc. logo
EVHCases — Revenue
$42.56M+4.8%
Omada Health, Inc. Common Stock logo
OMDAServices — Revenue
$69.59M+40.6%

Other financials

Income statement

See full
Revenue$67.4M+87.4%
Gross profit$14.1M+100%
Operating income-$3.0M+47.7%
Net income$2.2M+162%
EPS (diluted)$0.03+175%

Balance sheet

See full
Cash & equivalents$59.0M+65.3%
Total debt$4.5M-50.7%
Total equity$285.7M+30.0%
Total assets$327.6M+30.8%

Cash flow

See full
Operating cash flow$3.9M+1,679%
CapEx$5.2M+98.1%
Free cash flow-$1.3M+54.8%

Valuation

See full
Market cap$463.78M+24.0%
Enterprise value$409.26M
P/E8.9×
P/S1.8×

Profitability

See full
Gross margin21.7%+1.3pp
Operating margin-7.8%-2.8pp
Net margin21%+13.6pp
FCF margin-22.4%+1,712pp

Returns & leverage

See full
Return on equity15.6%+10.0pp
Debt / equity0.0×
Current ratio5.9×-1.0×

Where this comes from

Reported directly by SRTA in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: SRTA’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about SRTA's clinical — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SRTA's clinical — revenue?
SRTA (SRTA) reported clinical — revenue of $19.79M in Q1 2026.
What does clinical — revenue mean?
Represents the total gross income generated from the sale of products or services within the clinical business segment. This metric reflects the market adoption and commercial scale of the company's clinical-focused offerings. It serves as a primary indicator of the segment's top-line growth and revenue-generating capacity.